Lyell Immunopharma Inc. (LYEL)

LYEL trades at $17.75, 42.0% above the near-term max pain of $12.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($5-$17.5), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for LYEL shows an upward trend from 5 to 17.5, suggesting bullish positioning in longer-dated options. The 119% spread signals divergent expectations across timeframes. Most levels below 17.75 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.